Keyphrases
Immune Checkpoint Blockers
100%
Anti-PD-1
100%
Tumor-associated Macrophages
50%
Proton Irradiation
50%
Tumor
33%
Tumor Microenvironment
33%
Immunogenic Cell Death
33%
Tumor Survival
33%
In Vitro Cell Culture
33%
T Cells
16%
M2 Macrophages
16%
Immunosuppressive Properties
16%
Irradiation
16%
Myeloid Cells
16%
Immune Cells
16%
Proton Therapy
16%
M2-like
16%
Radiotherapy
16%
Tumor Eradication
16%
Immune Rejection
16%
X-ray
16%
Clinical Trials
16%
Macrophage Cells
16%
Tumor Size
16%
M1 Phenotype
16%
Survival Rate
16%
Treatment Response
16%
Precision Medicine
16%
Apoptosis
16%
Murine Tumor Model
16%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
16%
Tumor-immune System
16%
Cellular Compartments
16%
Macrophages
16%
Immunosuppressive Activity
16%
Cancer Cells
16%
Medicine and Dentistry
Proton Irradiation
100%
Neoplasm
100%
Programmed Death-Ligand 1
100%
Macrophage
100%
Immunosuppressive Drug
37%
In Vitro
25%
Radiation Therapy
12%
Myeloid Cell
12%
Cancer Cell
12%
Immunogenic Cell Death
12%
Clinical Trial
12%
Programmed Cell Death
12%
Head and Neck Squamous Cell Carcinoma
12%
Treatment Response
12%
Tumor Model
12%
Cell Compartment
12%
Protontherapy
12%
Tumor Microenvironment
12%
T Cell
12%
Immunocompetent Cell
12%
Survival Rate
12%
M2 Macrophages
12%
Immunotherapy
12%
Cell Culture
12%
INIS
macrophages
100%
irradiation
100%
protons
100%
tumors
100%
phenotype
30%
in vivo
30%
apoptosis
20%
in vitro
20%
immunotherapy
10%
compartments
10%
carcinomas
10%
humans
10%
conversion
10%
x radiation
10%
clinical trials
10%
cancer
10%
radiotherapy
10%
abundance
10%
size
10%
cell cultures
10%